We are live on
!
Find out more
DWA
Dorsey Wright & Associates Portfolio holdings
AUM
$590M
Turnover
51.79%
1-Year Est. Return
77.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.02%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.63%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$549M
AUM Growth
-$132M
(-19%)
Cap. Flow
-$157M
Cap. Flow
% of AUM
-28.53%
Top 10 Holdings %
Top 10 Hldgs %
20.95%
Holding
324
New
207
Increased
12
Reduced
69
Closed
36
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AerCap
AER
|
+$6.49M |
| 2 |
Logitech
LOGI
|
+$6.36M |
| 3 |
ZTO Express
ZTO
|
+$6.32M |
| 4 |
TotalEnergies
TTE
|
+$6.24M |
| 5 |
SHPG
Shire pic
SHPG
|
+$6.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edenor
EDN
|
+$15.9M |
| 2 |
Sociedad Química y Minera de Chile
SQM
|
+$14.8M |
| 3 |
SODA
SodaStream International Ltd
SODA
|
+$13.3M |
| 4 |
Ternium
TX
|
+$12M |
| 5 |
TAL Education Group
TAL
|
+$9.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Miscellaneous | 17.26% |
| 3 | Technology | 17.08% |
| 4 | Energy | 12.22% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Ooma
OOMA
$565M
| $16K | ﹤0.01% |
+937
| New | +$15K |
2018 Q3
0 quarters
|
|
202
Rocket Pharmaceuticals
RCKT
$243M
| $16K | ﹤0.01% |
+640
| New | +$13.9K |
2018 Q3
0 quarters
|
|
203
Trupanion
TRUP
$1.22B
| $16K | ﹤0.01% |
+460
| New | +$17.8K |
2018 Q3
0 quarters
|
|
204
Xenon Pharmaceuticals
XENE
$3.32B
| $16K | ﹤0.01% |
+1,184
| New | +$13.7K |
2018 Q3
0 quarters
|
|
|
KIN
205
DELISTED
Kindred Biosciences, Inc.
KIN
| $16K | ﹤0.01% |
+1,129
| New | +$15.3K |
2018 Q3
0 quarters
|
|
|
BFYT
206
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $16K | ﹤0.01% |
+263
| New | +$12K |
2018 Q3
0 quarters
|
|
|
CRCM
207
DELISTED
CARE.COM, INC.
CRCM
| $16K | ﹤0.01% |
+715
| New | +$14.3K |
2018 Q3
0 quarters
|
|
|
XOXO
208
DELISTED
Xo Group Inc
XOXO
| $16K | ﹤0.01% |
+465
| New | +$14.4K |
2018 Q3
0 quarters
|
|
|
MEET
209
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $16K | ﹤0.01% |
+3,264
| New | +$14.6K |
2018 Q3
0 quarters
|
|
|
ATTU
210
DELISTED
Attunity Ltd
ATTU
| $16K | ﹤0.01% |
+872
| New | +$14.8K |
2018 Q3
0 quarters
|
|
211
Ameresco
AMRC
$1.07B
| $15K | ﹤0.01% |
+1,070
| New | +$14.6K |
2018 Q3
0 quarters
|
|
212
Avalo Therapeutics
AVTX
$644M
| $15K | ﹤0.01% |
+1
| New | +$13.1K |
2018 Q3
0 quarters
|
|
213
Comtech Telecommunications
CMTL
$43.4M
| $15K | ﹤0.01% |
+415
| New | +$14.2K |
2018 Q3
0 quarters
|
|
214
Marker Therapeutics
MRKR
$15.3M
| $15K | ﹤0.01% |
+163
| New | +$14K |
2018 Q3
0 quarters
|
|
215
Oppenheimer Holdings
OPY
$1.09B
| $15K | ﹤0.01% |
+470
| New | +$14.5K |
2018 Q3
0 quarters
|
|
216
Rocky Brands
RCKY
$350M
| $15K | ﹤0.01% |
+543
| New | +$15.8K |
2018 Q3
0 quarters
|
|
217
DELISTED
Simulations Plus
SLP
| $15K | ﹤0.01% |
+720
| New | +$14.1K |
2018 Q3
0 quarters
|
|
218
Verastem
VSTM
$836M
| $15K | ﹤0.01% |
+174
| New | +$17.3K |
2018 Q3
0 quarters
|
|
219
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $15K | ﹤0.01% |
+2,202
| New | +$13.1K |
2018 Q3
0 quarters
|
|
|
QTNT
220
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $15K | ﹤0.01% |
+50
| New | +$15K |
2018 Q3
0 quarters
|
|
|
DRNA
221
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $15K | ﹤0.01% |
+975
| New | +$14.2K |
2018 Q3
0 quarters
|
|
|
VSLR
222
DELISTED
VIVINT SOLAR, INC.
VSLR
| $15K | ﹤0.01% |
+2,943
| New | +$15.6K |
2018 Q3
0 quarters
|
|
|
CARO
223
DELISTED
Carolina Financial Corp.
CARO
| $15K | ﹤0.01% |
+400
| New | +$16.6K |
2018 Q3
0 quarters
|
|
|
ARQL
224
DELISTED
Arqule Inc
ARQL
| $15K | ﹤0.01% |
+2,625
| New | +$14.9K |
2018 Q3
0 quarters
|
|
|
ASNA
225
DELISTED
Ascena Retail Group, Inc.
ASNA
| $15K | ﹤0.01% |
+164
| New | +$13.6K |
2018 Q3
0 quarters
|
|
Similar funds
AIM
ECM
DSC
SP
NWA
TC
SIM
FFA
Dorsey Wright & Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Dorsey Wright & Associates held 324 positions worth $549M, down 19% from $681M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Dorsey Wright & Associates withdrew a net $157M in Q3 2018, closing 36 positions and reducing 69 holdings. Its most notable exit was Edenor, an estimated $15.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 9.7% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, Dorsey Wright & Associates opened a new position in AerCap worth $6.61M.
- Dorsey Wright & Associates's largest Q3 2018 buy was AerCap: 114,870 shares worth $6.61M.
- Dorsey Wright & Associates added most to Bio-Rad Laboratories Class A in Q3 2018, an estimated $4.67M increase.
- Dorsey Wright & Associates's biggest Q3 2018 reduction was TAL Education Group, cutting an estimated $9.71M.
- Dorsey Wright & Associates fully exited Edenor in Q3 2018, selling an estimated $15.9M.
- Dorsey Wright & Associates's ten largest holdings make up 21% of its $549M portfolio in Q3 2018.
- Dorsey Wright & Associates opened 207 new positions and closed 36 in Q3 2018.
- Dorsey Wright & Associates's portfolio value fell 19% quarter-over-quarter to $549M.
Based on Dorsey Wright & Associates's 13F filing for Q3 2018, filed 12 Oct 2018.